Transient Expression of mRNA Lipid Nanoparticle-based Chimeric Antigen Receptors for Immunotherapy

Поделиться
HTML-код
  • Опубликовано: 12 сен 2024
  • Watch this on-demand webinar where Dr. Sandy Tretbar, Lead of ATMP Engineering Unit at Fraunhofer Institute for Cell Therapy and Immunology IZI (Fraunhofer IZI) discusses why mRNA-LNP-derived CAR T cells is a next-generation transient approach for clinical trials.

Комментарии •